Novo Nordisk APX expansion

Novo Nordisk’s new insulin filling facility in Hillerød, Denmark is extensive in both size and budget. The diabetes and obesity treatment facility uses the latest production technology and covers 10,300 m² with an investment of DKK 2.1 billion. NNE is supporting Novo Nordisk in all phases of the project towards a fully operational facility in 2019.